112
Participants
Start Date
June 30, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
July 31, 2015
Tofacitinib
5 mg twice daily of tofacitinib with background methotrexate for 12 weeks
Placebo
Placebo tablets twice daily with background methotrexate for 12 weeks
The Center for Rheumatology, LLP, Albany
Buffalo Rheumatology and Medicine, PLLC, Orchard Park
Altoona Center for Clinical Research, Duncansville
East Penn Rheumatology Associates, PC, Bethlehem
Clinical Research Center of Reading LLP, Wyomissing
Arthritis Treatment Center, Frederick
PMG Research of Salisbury, LLC, Salisbury
Novant Health Imaging Julian Road, Salisbury
Piedmont Rheumatology, P.A, Hickory
PMG Research of Hickory, LLC, Hickory
Palmetto Clinical Trial Services, LLC, Greenville
Jacksonville Center for Clinical Research, Jacksonville
Center for Arthritis and Rheumatic Diseases, Miami
Health Point Medical Group, Inc., Tampa
Suncoast Medical Clinic, St. Petersburg
Sun Coast Medical Clinic, St. Petersburg
DMI Research, Inc., Pinellas Park
Sarasota Arthritis Research Center, Sarasota
Suncoast Clinical Research, Inc., New Port Richey
Florida Arthritis and Osteoporosis Center, Port Richey
Gulf Coast Medical Center, Port Richey
Arthritis Clinic, Jackson
West Tennessee Research Institute, Jackson
Diagnostic Rheumatology And Research, PC, Indianapolis
Deerbrook Medical Associates, Vernon Hills
NEA Baptist Clinic, Jonesboro
Office of John P. Lavery, MD, PA, Allen
Baylor Research Institute Arthritis Care and Research Center, Dallas
Drug Shipping Address (IRB# 14-000826) Ronald Regan, Los Angeles
UCLA David Geffen School of Medicine, Los Angeles
Inland Rheumatology Clinical Trials, Inc., Upland
Pacific Arthritis Center Medical Group, Santa Maria
The Vancouver Clinic (Drug Shipment Only), Vancouver
The Vancouver Clinic, Inc, PS, Vancouver
Dartmouth-Hitchcock Medical Center, Lebanon
Rheumatology Consultants, PLLC, Knoxville
Lead Sponsor
Pfizer
INDUSTRY